STAT+: Pharmalittle: We’re reading about Trump boosting psychedelic treatment, the future for weight-loss drugs, and more
Stat News • 3/2/2026 – 4/20/2026
Summary
No summary yet.
Advertisement
Cluster Activity
1
3
1
2
1
1
2
1
1
2026-03-022026-04-20
Lindy Score Breakdown (V4.2)
5h
Age
1
Sources
from cluster
5
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier93% (0.5^5/48)
Hero EligibleYes
Story Timeline
- 2026-03-02
- 2026-03-03
- 2026-04-08
- 2026-04-09
- 2026-04-14
- 2026-04-15
- 2026-04-16
- 2026-04-17
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 11 sources
STAT+: Pharmalittle: We’re reading about Lilly weight loss pill trial results, slashed U.K. clinical trial times, and more
Stat News • 3 days ago
STAT+: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target
Stat News • 4 days ago
STAT+: Pharmalittle: We’re reading about a review of Alzheimer’s drugs, FDA interest in compounded peptides, and more
Stat News • 4 days ago
STAT+: FDA panel will meet to discuss allowing broader access to certain peptides
Stat News • 5 days ago
STAT+: Pharmalittle: We’re reading about an FDA push for trial transparency, a Novo-OpenAI deal, and more
Stat News • 6 days ago
STAT+: Pharmalittle: We’re reading about top pharma lobbyist stepping down, genes and GLP-1 drugs, and more
Stat News • 1 week ago
STAT+: Genetics may shape GLP-1 outcomes, slightly
Stat News • 1 week ago
STAT+: Steve Ubl to step down as CEO of PhRMA
Stat News • 1 week ago
STAT+: CMS wants more drugmakers to join Medicaid ‘most-favored nations’ pilot
Stat News • 1+ months
STAT+: Pharmalittle: We’re reading about an FDA-UniQure feud, Pfizer’s ‘problem’ with the agency, and more
Stat News • 1+ months
Breaking Similar stories
STAT+: Trump order to advance psychedelic treatments generates excitement — and worries
Stat News • Today
STAT+: PBMs warn Trump’s proposal to disclose drug prices is illegal
Stat News • Today
STAT+: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades
Stat News • 1 day ago
STAT+: Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride
Stat News • Today
STAT+: AACR 2026: More strong data for Revolution Medicines’ KRAS drug
Stat News • Today
How Trump is pushing psychedelics reform through the health agencies
Stat News • 2 days ago
STAT+: A controversy over research monkeys highlights ambiguity over health standards
Stat News • Today
STAT+: Extended use of Nektar Therapeutics drug shows promise in alopecia
Stat News • Today
STAT+: The PBMs fight back, and arbitration doesn’t lose
Stat News • Today
STAT+: Finally cracking KRAS as a druggable target
Stat News • Today